AI assistant
Sending…
LEAP THERAPEUTICS, INC. — Director's Dealing 2017
Jan 24, 2017
35080_dirs_2017-01-23_6e969c81-4031-4973-99bf-a4acd1a68ed5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LEAP THERAPEUTICS, INC. (LPTX)
CIK: 0001509745
Period of Report: 2017-01-20
Reporting Person: Dietz Thomas John (Director)
More from LEAP THERAPEUTICS, INC.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17